These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27922338)

  • 1. Pathophysiology of aortic aneurysm: insights from human genetics and mouse models.
    Wilson NK; Gould RA; Gallo MacFarlane E; Consortium ML
    Pharmacogenomics; 2016 Dec; 17(18):2071-2080. PubMed ID: 27922338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in a TGF-β ligand, TGFB3, cause syndromic aortic aneurysms and dissections.
    Bertoli-Avella AM; Gillis E; Morisaki H; Verhagen JMA; de Graaf BM; van de Beek G; Gallo E; Kruithof BPT; Venselaar H; Myers LA; Laga S; Doyle AJ; Oswald G; van Cappellen GWA; Yamanaka I; van der Helm RM; Beverloo B; de Klein A; Pardo L; Lammens M; Evers C; Devriendt K; Dumoulein M; Timmermans J; Bruggenwirth HT; Verheijen F; Rodrigus I; Baynam G; Kempers M; Saenen J; Van Craenenbroeck EM; Minatoya K; Matsukawa R; Tsukube T; Kubo N; Hofstra R; Goumans MJ; Bekkers JA; Roos-Hesselink JW; van de Laar IMBH; Dietz HC; Van Laer L; Morisaki T; Wessels MW; Loeys BL
    J Am Coll Cardiol; 2015 Apr; 65(13):1324-1336. PubMed ID: 25835445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights in the pathogenesis of aortic aneurysms.
    Loeys B; De Paepe A
    Verh K Acad Geneeskd Belg; 2008; 70(2):69-84. PubMed ID: 18630721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β Signaling-Related Genes and Thoracic Aortic Aneurysms and Dissections.
    Takeda N; Hara H; Fujiwara T; Kanaya T; Maemura S; Komuro I
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment.
    van Dorst DCH; de Wagenaar NP; van der Pluijm I; Roos-Hesselink JW; Essers J; Danser AHJ
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1233-1252. PubMed ID: 33283255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys-Dietz Syndromes.
    Takeda N; Yagi H; Hara H; Fujiwara T; Fujita D; Nawata K; Inuzuka R; Taniguchi Y; Harada M; Toko H; Akazawa H; Komuro I
    Int Heart J; 2016 May; 57(3):271-7. PubMed ID: 27181042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β signaling in aortic aneurysm: another round of controversy.
    Lin F; Yang X
    J Genet Genomics; 2010 Sep; 37(9):583-91. PubMed ID: 20933212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.
    Gomez D; Al Haj Zen A; Borges LF; Philippe M; Gutierrez PS; Jondeau G; Michel JB; Vranckx R
    J Pathol; 2009 May; 218(1):131-42. PubMed ID: 19224541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights on the Pathogenesis of Aneurysm through the Study of Hereditary Aortopathies.
    Creamer TJ; Bramel EE; MacFarlane EG
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33514025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.
    van de Laar IM; Oldenburg RA; Pals G; Roos-Hesselink JW; de Graaf BM; Verhagen JM; Hoedemaekers YM; Willemsen R; Severijnen LA; Venselaar H; Vriend G; Pattynama PM; Collée M; Majoor-Krakauer D; Poldermans D; Frohn-Mulder IM; Micha D; Timmermans J; Hilhorst-Hofstee Y; Bierma-Zeinstra SM; Willems PJ; Kros JM; Oei EH; Oostra BA; Wessels MW; Bertoli-Avella AM
    Nat Genet; 2011 Feb; 43(2):121-6. PubMed ID: 21217753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of the extracellular matrix in aortic aneurysmal diseases.
    Lin CJ; Lin CY; Stitziel NO
    Matrix Biol; 2018 Oct; 71-72():128-143. PubMed ID: 29656146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel pharmacological strategies for aortic dilation in Marfan syndrome: from mouse models to human patients].
    Perrino C; Schiattarella GG; Bottino R; Magliulo F; Oliveti M; Esposito G; Trimarco B
    G Ital Cardiol (Rome); 2014; 15(7-8):408-17. PubMed ID: 25174594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracic Aortic Aneurysm: A Clinical Review.
    Senser EM; Misra S; Henkin S
    Cardiol Clin; 2021 Nov; 39(4):505-515. PubMed ID: 34686263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility.
    Gillis E; Van Laer L; Loeys BL
    Circ Res; 2013 Jul; 113(3):327-40. PubMed ID: 23868829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of a new therapeutic target for the treatment of genetically triggered thoracic aortic aneurysms and cardiovascular conditions: insights from human and animal lathyrism.
    Sherif HM
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):271-6. PubMed ID: 20547706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of PPAR-gamma agonists and HMG CoA reductase inhibitors (statins) as a new therapy for the conservative treatment of AAS (aortic aneurysm syndromes).
    Sorice GP; Folli F
    Med Hypotheses; 2009 Oct; 73(4):614-8. PubMed ID: 19577852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of aortic aneurysms in patients with connective tissue disease.
    Schoenhoff F; Schmidli J; Czerny M; Carrel TP
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):125-34. PubMed ID: 23443597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.
    Doyle AJ; Doyle JJ; Bessling SL; Maragh S; Lindsay ME; Schepers D; Gillis E; Mortier G; Homfray T; Sauls K; Norris RA; Huso ND; Leahy D; Mohr DW; Caulfield MJ; Scott AF; Destrée A; Hennekam RC; Arn PH; Curry CJ; Van Laer L; McCallion AS; Loeys BL; Dietz HC
    Nat Genet; 2012 Nov; 44(11):1249-54. PubMed ID: 23023332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.